Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Roberto Pili is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 3, Randomized, Open-label Study of Belzutifan + Zanzalintinib Versus Cabozantinib in Participants with Advanced RCC who Experienced Disease Recurrence During or After Prior Adjuvant Anti-PD-1/L1 Therapy (LITESPARK-033)
Pili, R. (PI)
Merck Sharp and Dohme Limited Liability Corporation
06/4/26 → 10/31/27
Project: Research
-
-
Exploiting metabolic reprogramming of prostate cancer for new therapeutics
Pili, R. (PI)
US Army Medical Research Acquisition Activity
05/15/24 → 05/14/27
Project: Research
-
Identifying factors associated with vaping cessation in young adults: A machine learning and XAI approach
Satheeshkumar, P. S., Lango, I., Zafo, S., Ebanks, M., Das, R. K., Cheung, K. W., Pili, R. & Mahajan, S., May 2026, In: PLOS Digital Health. 5, 5 May, e0001031.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-Term Clinical Consequences of Severe Oral Mucositis in Survivors of Lip, Oral Cavity, and Pharynx Cancer Versus Leukemia: A Propensity-Score-Matched Comparative Cohort Study Using Real-World Data
Satheeshkumar, P. S., Gopalakrishnan, V., Epstein, J. B. & Pili, R., Mar 2026, In: Medical sciences. 14, 1, 142.Research output: Contribution to journal › Article › peer-review
Open Access -
Measurement of patients’ acceptable symptom levels and priorities for symptom improvement in advanced prostate cancer
Snyder, S., Secinti, E., Krueger, E. F., Adra, N., Pili, R., Hanna, N. H. & Mosher, C. E., Jan 2026, In: Supportive Care in Cancer. 34, 1, 63.Research output: Contribution to journal › Article › peer-review
Open Access -
MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
Gulla, S., Sharma, T., Gardner, E., Li, C., Purohit, T. A., Xue, C., Colligan, S., Shyam Sundar, S., Yang, B., Trostel, S. Y., Capaldo, B., Bard, J. E., Ogunbowale, T., Jawadwala, A., Ma, M., Qu, J., Karzai, F., Pili, R., Jarrard, D. F. & Sowalsky, A. G. & 2 others, , May 4 2026, In: Cancer Research. 86, 9, p. 2143-2160 18 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Oral mucositis as a predictor of differential long-term adverse events and mortality in breast cancer patients treated with monoclonal antibody-drug conjugates: Evidence from a propensity score-matched cohort comparison using real-world data from 88 U.S Healthcare organizations.
Mohan, M., Pili, R. & Poolakkad Sankaran, S. K., Jun 2026, In: Journal of Clinical Oncology. 44, 16, p. e12752-e12752Research output: Contribution to journal › Article › peer-review